首页|特布他林雾化联合干扰素治疗小儿支气管肺炎的疗效

特布他林雾化联合干扰素治疗小儿支气管肺炎的疗效

扫码查看
目的:分析特布他林雾化联合干扰素治疗小儿支气管肺炎的疗效.方法:选择本院 2020 年3 月至 2022 年3月收治的支气管肺炎患儿 60 例,随机将患儿分成对照组(n=30)和观察组(n=30).对照组患儿给予特布他林雾化治疗,观察组患儿给予特布他林雾化联合干扰素治疗.对比两组患儿临床症状消退时间、炎性因子水平[C-反应蛋白(C-reactive protein,CRP)、肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)]和疗效.结果:治疗 1 w 后,观察组临床症状消退时间低于对照组(P<0.05);观察组治疗后炎性因子TNF-α、CRP、IL-6 低于对照组(P<0.05);观察组治疗总有效率高于对照组(P<0.05).结论:特布他林雾化联合干扰素治疗支气管肺炎患儿能有效缩短临床症状消退时间,降低炎性因子,疗效显著.
Therapeutic effect of terbutaline atomization combined with interferon on bronchopneumonia in children
Objective:To analyze the curative effect of terbutaline aerosol combined with interferon in the treatment of bronchopneumonia in children.Methods:60 children with bronchopneumonia admitted to our hospital from March 2020 to March 2022 were randomly divided into control group(n=30)and observation group(n=30).Control group was given terbutaline atomization therapy,observation group was given Terbutaline atomization combined with interferon therapy.The time to resolve clinical symptoms,the level of inflammatory factors[C-reactive protein(CRP),Tumor necrosis factor-α(TNF-α),and Interleukin-6 IL-6)]in the two groups were compared.and efficacy.Results:After 1 week of treatment,the time of clinical symptom resolution in observation group was lower than that in control group(P<0.05).After treatment,the inflammatory factors TNF-α,CRP and IL-6 in observation group were lower than those in control group(P<0.05).The total effective rate of observation group was higher than that of control group(P<0.05).Conclusion:Terbutaline atomization combined with interferon in the treatment of children with bronchopneumonia can effectively shorten the time of clinical symptoms resolution,reduce inflammatory factors,and have a significant effect.

Terbutaline atomizationInterferonBronchopneumonia

饶庆寿

展开 >

上高县中医院儿科,江西 宜春 336400

特布他林雾化 干扰素 支气管肺炎

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(6)